These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9282976)

  • 1. Effect of suramin on human esophageal cancer cells in vitro and in vivo.
    Shin R; Naomoto Y; Kamikawa Y; Tanaka N; Orita K
    Scand J Gastroenterol; 1997 Aug; 32(8):824-8. PubMed ID: 9282976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
    Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
    J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of gefitinib ('Iressa') on esophageal squamous cell carcinoma cell lines in vitro and in vivo.
    Hara F; Aoe M; Doihara H; Taira N; Shien T; Takahashi H; Yoshitomi S; Tsukuda K; Toyooka S; Ohta T; Shimizu N
    Cancer Lett; 2005 Aug; 226(1):37-47. PubMed ID: 16004931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Suramin activity in human head and neck squamous cell carcinoma cell lines].
    Li AT
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(2):108-9, 125. PubMed ID: 8217281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
    Kalli KR; Bradley SV; Fuchshuber S; Conover CA
    Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of insulin like growth factor II autocrine growth of Wilms' tumor by suramin in vitro and in vivo.
    Vincent TS; Hazen-Martin DJ; Garvin AJ
    Cancer Lett; 1996 May; 103(1):49-56. PubMed ID: 8616808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of bufalin on proliferation and apoptosis through ERK/RSK2 pathway in human esophageal carcinoma cell line xenografts in nude mice].
    Yue M; Liu XJ; Ding Y; Wang XL; Yang HC; Liu YP
    Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):325-32. PubMed ID: 27188603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
    Thalmann GN; Sikes RA; Chang SM; Johnston DA; von Eschenbach AC; Chung LW
    J Natl Cancer Inst; 1996 Jun; 88(12):794-801. PubMed ID: 8637045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of growth stimulation by suramin in non-small-cell lung cancer cell lines.
    Lokshin A; Peng X; Campbell PG; Barsouk A; Levitt ML
    Cancer Chemother Pharmacol; 1999; 43(4):341-7. PubMed ID: 10071987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suramin inhibits the growth of malignant mesothelioma in vitro, and in vivo, in murine flank and intraperitoneal models.
    Cook JW; Sterman DH; Singhal S; Smythe WR; Kaiser LR
    Lung Cancer; 2003 Dec; 42(3):263-74. PubMed ID: 14644513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of tumor growth in vitro and in vivo by suramin on the VX2 model.
    Ramirez LH; Juliéron M; Bonnay M; Koscielny S; Zhao Z; Gouyette A; Munck JN
    Invest New Drugs; 1995; 13(1):51-3. PubMed ID: 7499108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The enhancement of the chemotherapeutic effects on human prostate cancer cell--the combination with the growth factor interaction inhibitor (suramin)].
    Suzuki Y; Miwa Y; Akino H; Fujita T; Saikawa S; Kanimoto Y; Okada K
    Hinyokika Kiyo; 1993 Dec; 39(12):1215-20. PubMed ID: 8285172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suramin interferes with auto/paracrine insulin-like growth factor I-controlled proliferative loop on human lung cancer cell lines.
    Favoni RE; Ravera F; Pirani P; Ardizzoni A; Noonan D; de Cupis A
    Eur J Pharmacol; 1994 Oct; 264(2):199-206. PubMed ID: 7851483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative effects of suramin on human cancer cells in vitro and in vivo.
    Bai L; Naomoto Y; Miyazaki M; Orita K; Namba M
    Acta Med Okayama; 1992 Dec; 46(6):457-63. PubMed ID: 1485540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suramin selectively inhibits carcinoma cell growth that is dependent on extracellular polyamines.
    Sandgren S; Belting M
    Anticancer Res; 2003; 23(2B):1223-8. PubMed ID: 12820375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of suramin on human lung cancer cell line in vitro].
    Fujiuchi S; Tsuji T; Ohsaki Y; Kikuchi K
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):647-52. PubMed ID: 8154891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of trapidil and suramin on growth factor-induced calcium response and tyrosine phosphorylation in human glioma cells.
    Bando K; Kannuki S; Rokutan K; Shouno M; Matsumoto K
    Neurol Med Chir (Tokyo); 1995 Sep; 35(9):631-8. PubMed ID: 7566395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of suramin against human prostate carcinoma DU145 xenografts in nude mice.
    Church D; Zhang Y; Rago R; Wilding G
    Cancer Chemother Pharmacol; 1999; 43(3):198-204. PubMed ID: 9923549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative effect of suramin on primary cultures of human pheochromocytomas and rat PC12 pheochromocytoma cells.
    Zielke A; Wong MG; Siperstein AE; Clark OH; Rothmund M; Duh QY
    J Surg Oncol; 1997 Sep; 66(1):11-8. PubMed ID: 9290687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.